Pitcairn CO Shockwave Medical, Inc. Transaction History

Pitcairn CO

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$194.33 - $283.97 $20,210 - $29,532	-104 Reduced 9.11%	1,037 $206,000
Q2 2023 Aug 11, 2023	SELL	$223.05 - $302.68 $255,615 - $346,871	-1,146 Reduced 50.11%	1,141 $325,000
Q1 2023 May 05, 2023	BUY	$175.41 - $217.92 $51,044 - $63,414	291 Added 14.58%	2,287 $495,000
Q4 2022 Feb 13, 2023	SELL	$204.38 - $296.82 $5,722 - $8,310	-28 Reduced 1.38%	1,996 $410,000
Q3 2022 Nov 10, 2022	SELL	$195.21 - $310.53 $42,360 - $67,385	-217 Reduced 9.68%	2,024 $563,000
Q2 2022 Aug 12, 2022	BUY	$115.91 - $214.48 $18,313 - $33,887	158 Added 7.59%	2,241 $428,000
Q1 2022 May 12, 2022	SELL	$127.96 - $207.36 $35,061 - $56,816	-274 Reduced 11.62%	2,083 $432,000
Q4 2021 Feb 14, 2022	BUY	$165.13 - $241.83 $389,211 - $569,993	2,357 New	2,357 $420,000

321K

1.9K

Ticker SWAV
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,927,100
Description
ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease ...

Get notified when there are updates to the investment portfolio of Pitcairn CO, based on Form 13F filings with the SEC.

Stay updated on Pitcairn CO with notifications on news.